Search - Université Clermont Auvergne Access content directly

Filter your results

10 Results
authIdHal_s : mathilde-hunault-berger

Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO Trial

Arnaud Pigneux , Marie Béné , Louis-Rachid Salmi , Pierre-Yves Dumas , Jacques Delaunay et al.
Journal of Clinical Oncology, 2018, 36 (32), pp.3203-3210. ⟨10.1200/JCO.2018.78.7366⟩
Journal articles hal-02874606v1

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Laetitia Largeaud , Pascale Cornillet-Lefebvre , Jean-François Hamel , Pierre-Yves Dumas , Naïs Prade et al.
Leukemia, 2021, 35 (5), pp.1291-1300. ⟨10.1038/s41375-020-01031-1⟩
Journal articles hal-03441014v1

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial

Anne Bouvier , Jean-Francois Hamel , Jacques Delaunay , Eric Delabesse , Pierre-Yves Dumas et al.
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
Journal articles hal-03604930v1
Image document

Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study

Arnaud Pigneux , Marie C Béné , Philippe Guardiola , Christian C Recher , Jean-Francois Hamel et al.
Journal of Clinical Oncology, 2017, 35 (4), pp.387-393. ⟨10.1200/JCO.2016.67.6213⟩
Journal articles inserm-01480651v1

Prospective, Multicentric Phase II Randomized Trial Comparing the Efficacy of Methotrexate or Cyclophosphamide in Large Granular Lymphocytic Leukemia: A French National Study. Report on the Interim Analysis

T. Lamy , C. Pastoret , R. Houot , Loic Ysebaert , M. Hunault et al.
61st Annual Meeting and Exposition of the American Society of Hematology, Dec 2019, Orlando, United States. 134 (Suppl 1), pp.1545, 2019, Blood
Conference poster hal-02427556v1

Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Diagnosis and Treatment in a Retrospective Cohort of Thirty Patients

Anne Wanquet , Rudy Birsen , Sylvain Choquet , Vincent Levy , Jehan Dupuis et al.
Blood, 2015, 126 (23), pp.2948
Journal articles hal-01290433v1

Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party

Johannes Schetelig , Patrice Chevallier , Michel van Gelder , Jennifer Hoek , Olivier Hermine et al.
Bone Marrow Transplantation, 2021, ⟨10.1038/s41409-021-01516-2⟩
Journal articles hal-03440115v1

L’ajout de la lomustine bénéficie aux leucémies myéloïdes aiguës du sujet âgé avec cytogénétique non-défavorable et d’un profil moléculaire à haut risque de l’European Leukemia Net 2017

L. Largeaud , P. Cornillet-Lefebvre , J.F. Hamel , P.Y. Dumas , N. Prade et al.
40e Congrès de la Société Française d’Hématologie, Sep 2020, Paris, France. 26 (S4), pp.64, 2020, Hématologie
Conference poster hal-02945560v1

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Arnaud Pigneux , Christian Récher , Marie C. Bene , Julien Asselineau , Ariane C. Mineur et al.
Blood, 2015, 126 (23)
Journal articles hal-01295674v1

Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies

Lionel Adès , Thomas Prebet , Aspasia Stamatoullas , Christian Recher , Romain Guiéze et al.
Haematologica, 2017, 102 (4), pp.728 - 735. ⟨10.3324/haematol.2016.151894⟩
Journal articles hal-01655899v1